U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) Director Nancy Ham sold 1,172 shares of the stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $96.72, for a total transaction of $113,355.84. Following the completion of the transaction, the director now directly owns 1,112 shares of the company’s stock, valued at $107,552.64. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
U.S. Physical Therapy Price Performance
U.S. Physical Therapy stock opened at $92.17 on Wednesday. The stock’s 50 day moving average is $83.92 and its 200 day moving average is $91.25. U.S. Physical Therapy, Inc. has a one year low of $76.18 and a one year high of $113.63. The firm has a market cap of $1.39 billion, a P/E ratio of 98.05, a P/E/G ratio of 4.28 and a beta of 1.38. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.88.
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last posted its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The firm had revenue of $167.19 million during the quarter, compared to the consensus estimate of $163.34 million. During the same period in the prior year, the company posted $0.76 earnings per share. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. As a group, research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.
U.S. Physical Therapy Dividend Announcement
Analyst Upgrades and Downgrades
A number of research firms recently issued reports on USPH. Barrington Research reiterated an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research report on Thursday, November 7th. Bank of America restated a “neutral” rating and issued a $90.00 price target (down from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th. Finally, StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st.
Check Out Our Latest Research Report on USPH
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. boosted its position in shares of U.S. Physical Therapy by 1.0% during the 1st quarter. Vanguard Group Inc. now owns 1,072,602 shares of the company’s stock valued at $121,065,000 after purchasing an additional 10,175 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of U.S. Physical Therapy by 2.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company’s stock worth $39,173,000 after buying an additional 10,462 shares during the period. Envestnet Asset Management Inc. grew its position in shares of U.S. Physical Therapy by 4.1% during the 2nd quarter. Envestnet Asset Management Inc. now owns 239,982 shares of the company’s stock worth $22,179,000 after buying an additional 9,434 shares during the period. Bank of New York Mellon Corp increased its stake in shares of U.S. Physical Therapy by 3.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 157,052 shares of the company’s stock valued at $14,515,000 after acquiring an additional 5,111 shares in the last quarter. Finally, Bahl & Gaynor Inc. lifted its position in shares of U.S. Physical Therapy by 1.5% during the 2nd quarter. Bahl & Gaynor Inc. now owns 106,476 shares of the company’s stock valued at $9,841,000 after acquiring an additional 1,623 shares during the period.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Articles
- Five stocks we like better than U.S. Physical Therapy
- What Are Some of the Best Large-Cap Stocks to Buy?
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- What is the S&P 500 and How It is Distinct from Other Indexes
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- What Investors Need to Know to Beat the Market
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.